Insight tag
12 related stories.
FDA issued a GenAI-enabled medical-device discussion paper on August 18, 2026, seeking public input on risk, premarket evaluation and postmarket monitoring.
Read analysisOpenAI announced ChatGPT for Clinicians on April 22, 2026, offering a clinician-focused workspace for verified U.S. physicians, NPs, PAs and pharmacists.
Read analysisNVIDIA announced a BioNeMo platform expansion on January 12, 2026, naming Clara models, training recipes and data-processing libraries for AI-driven biology research.
Read analysisAnthropic introduced Claude for Healthcare on January 11, 2026, describing HIPAA-ready products, healthcare connectors and expanded life-science platform integrations.
Read analysisOpenAI introduced OpenAI for Healthcare on January 8, 2026, including ChatGPT for Healthcare for organizational clinical, research and administrative workspaces.
Read analysisGoogle’s MedASR release artifact records December 18, 2025 for a 105-million-parameter Conformer model built for medical speech transcription and adaptation.
Read analysisGoogle Research outlined a Personal Health Agent research prototype on September 30, 2025, pairing wearable and health data with specialist subagents in a non-product study.
Read analysisConnecticut signed SB 10 on June 24, 2025, barring health carriers from using AI or another algorithm instead of clinical-peer review for adverse determinations.
Read analysisGoogle announced MedGemma on May 22, 2025, describing Gemma 3-based 4B multimodal and 27B text models for developers researching medical text and image applications.
Read analysisOpenAI released HealthBench on May 12, 2025, a public benchmark of 5,000 health conversations scored against physician-created rubrics for model evaluation.
Read analysisGoogle Research presented multimodal AMIE on May 1, 2025, extending its research diagnostic-dialogue work to images and documents in simulated conversations.
Read analysisFDA’s January 7, 2025 draft proposed lifecycle and submission documentation for AI-enabled devices, but it was nonbinding draft guidance rather than a new enforceable rule.
Read analysis
